Cold War tensions and the polio vaccine polio vaccine. By the 1950, Jonas Salk had tested both live, attenuated polio vaccines and formaldehyde killed polio vaccines in monkeys and by 1952, began testing on humans. The killed vaccine was found to be effective, with proper filtration of the biological culture. A problem with this vaccine was the perception that to be adequately protected; a child had to get three Salk shots, properly spaced, and a recommended booster shot once a year, which was expensive. It should be noted however, that Jonas Salk, himself, has stated in interviews that this perception is not at all true. This vaccine
Remune P < 0.05 & HIV-1 lymphocyte proliferation P < 0.001 both favoring the Remune Group. The International AIDS Vaccine Research (IAVA) issued a report on “Whole Killed AIDS Vaccines” in 1999 reviewing a diverse aspect of the killed virus approach. Remune Remune is the first therapeutic HIV vaccine based on the killed whole virus approach. Remune was initially invented by Jonas Salk in 1987 and is now being developed by Immune Response BioPharma, Inc. (IRBP) Remune is a therapeutic HIV/AIDS vaccine that has completed over 25 clinical studies to date and shows a robust mechanism of action restoring white blood